Michele Benedetti
Overview
Explore the profile of Michele Benedetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pandolfini L, Conti D, Ballo P, Rollo S, Falsetto A, Paroli G, et al.
Perioper Med (Lond)
. 2025 Feb;
14(1):14.
PMID: 39905571
Background: It is common to observe a gap between the day on which the discharge criteria are reached and the actual day of discharge after colorectal surgery. The aim of...
2.
Stefano E, Rovito G, Cossa L, Castro F, Vergaro V, Ali A, et al.
Bioinorg Chem Appl
. 2025 Jan;
2024:5588491.
PMID: 39886428
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive type of solid tumor that is becoming more common. -[PtCl (NH)] (in short cisplatin or CDDP) has been shown to be effective...
3.
Muscella A, Cossa L, Stefano E, Rovito G, Benedetti M, Fanizzi F, et al.
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769425
This study examined the response to cisplatin in BxPC-3, Mia-Paca-2, PANC-1, and YAPC pancreatic cancer lines with different genotypic and phenotypic characteristics, and the mechanisms associated with their resistance. BxPC-3...
4.
Catarci M, Montemurro L, Benedetti M, Ciano P, Millarelli M, Chiappa R
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458075
Due to their proximity to the left renal hilum, injuries to the superior mesenteric artery and celiac trunk are still reported during left radical nephrectomy, whether performed via open, laparoscopic,...
5.
Stefano E, Castro F, Ciccarese A, Muscella A, Marsigliante S, Benedetti M, et al.
Int J Mol Sci
. 2024 Aug;
25(16).
PMID: 39201255
Neuroendocrine neoplasms (NENs) are a diverse group of malignancies with a shared phenotype but varying prognosis and response to current treatments. Based on their morphological features and rate of proliferation,...
6.
Ali A, Stefano E, Castro F, Ciccarella G, Rovito G, Marsigliante S, et al.
Chemistry
. 2024 May;
30(38):e202401064.
PMID: 38703115
Platinum-based chemotherapeutic agents are widely used in the treatment of cancer. However, their effectiveness is limited by severe adverse reactions, drug resistance, and poor water solubility. This study focuses on...
7.
De Luca E, Wang Y, Baars I, Castro F, Lolaico M, Migoni D, et al.
Int J Mol Sci
. 2023 Dec;
24(23).
PMID: 38069036
The DNA origami method has revolutionized the field of DNA nanotechnology since its introduction. These nanostructures, with their customizable shape and size, addressability, nontoxicity, and capacity to carry bioactive molecules,...
8.
Catarci M, Guadagni S, Masedu F, Ruffo G, Viola M, Borghi F, et al.
Updates Surg
. 2023 Oct;
76(1):107-117.
PMID: 37851299
Retrospective evaluation of the effects of mechanical bowel preparation (MBP) on data derived from two prospective open-label observational multicenter studies in Italy regarding elective colorectal surgery. MBP for elective colorectal...
9.
Castro F, Stefano E, Fanizzi F, Di Corato R, Abdalla P, Luchetti F, et al.
Molecules
. 2023 Oct;
28(19).
PMID: 37836603
The therapeutic advantages of some platinum complexes as major anticancer chemotherapeutic agents and of nucleoside analogue-based compounds as essential antiviral/antitumor drugs are widely recognized. Red blood cells (RBCs) offer a...
10.
Stefano E, Cossa L, Castro F, De Luca E, Vergaro V, My G, et al.
Bioinorg Chem Appl
. 2023 Sep;
2023:5564624.
PMID: 37727647
Pancreatic cancer is one of the most lethal malignancies with an increasing incidence and a high mortality rate, due to its rapid progression, invasiveness, and resistance to anticancer therapies. In...